about
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayc...
Read More
98.60
-2.89
(-2.85%)
2.9M
XNAS Volume
XNAS 31 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Insmed Inc is on 07 Aug 2026 for the purpose of Insmed Inc Second Quarter Earnings Results for 2026
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Insmed Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..